Real Relief Tablet
NDC Package 71971-6030-5
Package Information
Real Relief (allium cepa, aralia racemosa, arsenicum album, cuprum metallicum, euphrasia officinalis, nux vomica, sabadilla, sticta pulmonaria) tablets is usesThis homeopathic remedy to relieve from symptoms of all allergiesNasal congestionSneezingRunny noseItchy, watery eyes. This formulation utilizes a tablet delivery system. Marketed by Homeolab International (canada) Inc, this product is identified by NDC 71971-6030.
Identification & Billing
Clinical Specifications
- Allergens - [CS]
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Copper - [CS]
- Copper-containing Intrauterine Device - [EPC] (Established Pharmacologic Class)
- Decreased Embryonic Implantation - [PE] (Physiologic Effect)
- Decreased Sperm Motility - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Inhibit Ovum Fertilization - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
- Vegetable Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 71971 - Homeolab International (canada) Inc
- 71971-6030 - Real Relief
- 71971-6030-5 - 30 TABLET in 1 BOTTLE
- 71971-6030 - Real Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (71971-6030). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71971-6030-5 identifies a specific commercial package of 30 tablet in 1 bottle of Real Relief, a human over the counter drug labeled by Homeolab International (canada) Inc. This tablet is formulated for oral use and contains aralia racemosa root; arsenic trioxide; copper; euphrasia stricta; lobaria pulmonaria; onion; schoenocaulon officinale seed; strychnos nux-vomica seed as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Homeolab International (canada) Inc on January 01, 2020. The current certification is valid through December 31, 2026.
How is this Homeolab International (canada) Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71971603005. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.